Previous 10 | Next 10 |
Special purpose acquisition company Soaring Eagle Acquisition Corp. combined with Ginkgo Bioworks to form publicly listed Ginkgo Bioworks Holdings Inc., in what is the largest-ever biotechnology go-public transaction Ginkgo Bioworks is known for its work in the commercial-scale producti...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! It’s time to get right back into investing with a look at the biggest pre-market stock movers for Tuesday! Source: f11photo/Shutterstock.com News moving shares in early morning trading t...
Gainers: ION Geophysical (NYSE:IO) +42%. Valneva (NASDAQ:VALN) +33%. Progenity (NASDAQ:PROG) +31%. MeiraGTx (NASDAQ:MGTX) +30%. BTCS (NASDAQ:BTCS) +22%. Peabody Energy (NYSE:BTU) +20%. Evolving Systems (NASDAQ:EVOL) +18%. InMed (NASDAQ:INM) +16%. TORM (NASDAQ:TRMD) +17%. Aerovate (NASDAQ:AVTE...
ION Geophysical (NYSE:IO) +45% sees Q3 revenues more than doubling Q/Q Valneva SE (NASDAQ:VALN) +36% after topline results from late-stage VLA2001 COVID-19 trial Adamis Pharmaceuticals (NASDAQ:ADMP) +35% after FDA approves opioid overdose treatment ZIMHI MeiraGTx...
InMed Pharmaceuticals (NASDAQ: INM) , a leader in the manufacturing and clinical development of rare cannabinoids, has finalized the acquisition of BayMedica Inc., a private company based in the U.S. specializing in the manufacturing and commercialization of rare cannabinoids for the health...
NRx Pharmaceuticals (NASDAQ:NRXP) +36% on positive aviptadil data in Critical COVID-19 KORE Wireless (NYSE:KORE) +35%. TSR (NASDAQ:TSRI) +31% on Q1 earnings. Grove (NASDAQ:GRVI) +21 on launch of Amazon aggregation division Cemtrex (NASDAQ:CETX) +21%. Offerpad Solutions (NY...
VANCOUVER, British Columbia and SOUTH SAN FRANCISCO, Calif., Oct. 13, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the manufacturing and clinical development of rare cannabinoids, today announced th...
InMed Pharmaceuticals (NASDAQ: INM) recently announced it had signed a definitive agreement to acquire 100% of BayMedica Inc., a U.S.-based private company specializing in the manufacture and commercialization of rare cannabinoids. InMed CEO Eric A. Adams described the acquisition as a tra...
Are These Robinhood Penny Stocks on Your October Watchlist? If you’re making a list of penny stocks to buy, Robinhood could be a great resource to use. Over the past few years, Robinhood has become a defining factor in the trajectory of the stock market. The investing platform al...
Superior Drilling Products (NYSE:SDPI) +46%. Camber Energy (NYSE:CEI) +16%. Aemetis (NASDAQ:AMTX) +22% signs offtake agreement with Delta Air Lines for 250 million gallons of sustainable aviation fuel Onion Global (NYSE:OG) +17% to launch the "LUCA Elite Club" events in its KOC Comm...
News, Short Squeeze, Breakout and More Instantly...
InMed Pharmaceuticals Inc. Company Name:
INM Stock Symbol:
NASDAQ Market:
InMed Pharmaceuticals Inc. Website:
InMed Pharmaceuticals (NASDAQ: INM) , a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, is reporting on positive results from a long-term study of INM-901. The in vivo preclinical Alzheimer's di...
Results confirm improvements in cognitive function, memory and locomotor activity Achieved statistical significance in certain behavioral assessments Additional molecular analyses ongoing to elucidate INM-901 mechanisms of action Vancouver, British Columbia--(Newsfile Corp. - July 30,...
Age-related macular degeneration is a disease significantly impacting the quality of life, making it difficult for individuals to perform everyday activities such as reading, driving, and recognizing faces InMed is currently developing a pipeline of drugs, like INM-089, to treat diseases with a...